Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by ripantuckon Feb 23, 2012 11:30am
389 Views
Post# 19573282

Big Picture

Big Picture

GPD hitting a couple of impressive high grade intercepts is probably a bit overdue considering the expertise and land holdings they have.  But, it will happen again multiple times in the next couple of years.  Also, they almost certainly will continue to hit significant and shallow mineralization in excess of 50% of the holes they drill. They have  royalty interests and I would bet Sherriff adds to those as he goes along.

They are also set to begin small scale production within the next year or so.  Even with delays, probably by mid-2013.

The big picture is that they are well funded and they are in the process of developing a mid-level gold mining company with multiple projects.  Psychology is a strange thing.  They have been regularly hitting low to mid grade shallow intercepts and it is obvious that they are proving up what will become very large, if not massive deposits from those.  It was simply a matter of time before they hit a couple of high grade holes, yet the market did not believe it.  Otherwise the SP would already be well over a dollar.

This company has the very real possibility of making patient medium to long term investors rich.  For a junior it is very low risk if one invests for a minimum of 2 to 3 years.  Of course there are many good juniors out there now with similar prospects, but this is one of the best.  I suggest anyone who wants to short cut his/her DD time and effort go back and look at Scottiepimp's excellent DD writeup from last year, then look at developments since that time.

Sorry to sound like a pumper but I have lost money on several gold juniors this past year, including GPD. Some may come back or not, but none have the combination of land holdings, expert dedicated management,  drill results, cash, business momentum depressed SP that GPD has, even after today's runup.

Rip

 

 

Bullboard Posts